PSA Test: Should You Get One? UK Guide (2026)

What is a PSA test?

The prostate is a walnut-sized gland below the bladder that makes some of the fluid in semen. PSA (prostate specific antigen) is a protein made by the prostate. A PSA test is a blood test that measures how much is in your blood. A raised level can be a sign of prostate cancer, but it is also raised by an enlarged prostate, infection, recent ejaculation, vigorous exercise or cycling.

Does the NHS screen for prostate cancer?

Not for most men. The NHS says routine PSA testing is not offered unless genetic tests show you carry a faulty BRCA2 gene. Instead, the long-standing approach (the Prostate Cancer Risk Management Programme) is "informed choice": men can ask their GP for a PSA test, and the GP should explain the benefits and risks first. Pulse reports that any man over 50 can currently request one.

What did the UK National Screening Committee decide?

On 28 May 2026 the UK National Screening Committee (UK NSC) published its final recommendation, after a draft in November 2025 and a 12-week consultation (Cancer Research UK):

• Recommended: a PSA test every two years for men aged 45 to 61 with a BRCA2 gene change and a family history of breast, ovarian, pancreatic or prostate cancer.
• Dropped from the draft: men with BRCA1 changes, because newer evidence did not consistently show higher risk of aggressive cancer.
• Not recommended: screening all men, because too many would be overdiagnosed (found to have slow cancers that would never have harmed them) for too few to benefit.
• Not recommended for now: targeted screening of Black men, or men with a family history but no BRCA2 change, because it is not yet clear whether benefits outweigh harms. The large TRANSFORM trial is designed to answer this.

Ministers in each UK nation must now decide how to roll it out, which is likely to take time. Until then, the informed-choice route through your GP stays in place for everyone else, and men with known BRCA2 changes are already offered PSA testing on the NHS. The committee last reviewed prostate screening in 2020, when it recommended against any national programme, so the 2026 decision is a modest but real shift towards targeting people at highest genetic risk.

What does the evidence say?

The 2026 Cochrane review concluded screening likely reduces deaths from prostate cancer and may reduce overall deaths, but found too little evidence on harms from biopsies and treatment. The UK's own CAP trial found a single PSA invitation reduced prostate cancer deaths after 15 years, but the absolute reduction was small.

What are the pros and cons of a PSA test?

Possible benefits

• It can find cancer early, before symptoms, when treatment is more likely to work.
• A normal result can be reassuring.

Possible harms

• False positives: many men with a raised PSA turn out not to have cancer; the NHS stresses that a high PSA does not mean you have cancer. A raised result can still mean worry, an MRI scan and sometimes a biopsy.
• False negatives: some prostate cancers, including some aggressive ones, do not raise PSA, so a normal result is not a guarantee.
• Overdiagnosis: finding slow-growing cancers that would never have caused problems, leading to treatment that can cause erection problems and incontinence.

MRI scans before biopsy have reduced some of these harms in recent years, but not removed them. Many low-risk cancers are now monitored with regular PSA tests and scans (active surveillance) rather than treated straight away, which also reduces harm from overdiagnosis. Even so, being told you have cancer, however slow-growing, is a heavy thing to live with, and that is part of the decision too.

Who is at higher risk?

Prostate Cancer UK says about 1 in 8 men in the UK will be diagnosed in their lifetime, rising to about 1 in 4 Black men. Risk also rises with age and with a family history of prostate cancer (or of breast or ovarian cancer, which can signal BRCA genes). The charity suggests men in these groups talk to their GP from age 45.

What about home PSA test kits?

Several private companies sell finger-prick PSA tests or PSA add-ons to blood panels. We have not listed any. The test itself is the same lab measurement, but buying it without a GP conversation skips the informed-choice step the NHS considers important. Finger-prick samples can also be less reliable, and many kits do not tell you to avoid ejaculation, exercise and cycling for 48 hours beforehand, as the NHS advises. If you do get a raised result privately, take it to your GP, who will usually repeat it before referring you.

Who might reasonably ask for a test?

• Men over 50 who have weighed the pros and cons.
• Black men and men with a family history from age 45.
• Men who know they carry a BRCA2 change.
• Anyone with symptoms (peeing more often, especially at night, a weak flow, blood in urine or semen, erection problems) should see a GP whatever their age. That is diagnosis, not screening.

What should I ask my GP?

• Given my age, ethnicity and family history, what is my risk?
• If my PSA is raised, what happens next, and how likely is a biopsy?
• What would treatment involve if a slow-growing cancer is found, and is "active surveillance" (monitoring instead of treating) an option?
• Should I avoid anything before the test, such as exercise, cycling or ejaculation?
• How often would I need to repeat the test?

Prostate Cancer UK also runs a Risk Information Service and a 30-second online risk checker, which can help you prepare.

Bottom line

A PSA test is a personal choice, not a routine check. It can find cancers early but also finds many that would never have caused harm. If you are over 50, or over 45 and Black or with a family history, ask your GP to talk it through. Prostate Cancer UK has a 30-second online risk checker that can help you prepare. Avoid ordering a home kit without that conversation.